Summary:
Are You Currently Being Treated for a Relapsing Remitting Form of Multiple Sclerosis?
A voluntary research study is currently being conducted to evaluate different medication that treat relapsing remitting form of multiple sclerosis (MS).
Qualified Participants Must:
• Be between 18 and 65 years of age
•
Have been diagnosed with relapsing remitting form of MS
•
Be naïve to treatment or have been treated with no more than one approved first- line treatment for less than or equal to a total of five years
Qualified Participants May Receive:
Study-related exams and study medication at no cost.